AI
AMGEN INC
AMGN· Health Care· BiotechnologyS&P 500
Close · 16/09/2026
376.35
1D
+0.19%52-week range
269.77 – 447.03
Volume
24,01,300.00
Price history
AMGN
17/08/2026 to 16/09/2026
O 377.01 H 379.11 L 374.46
1W-3.81%
1M-10.26%
3M+8.20%
6M+4.21%
1Y+37.15%
3Y+43.80%
5Y+70.39%
MAX+53.80%
Fundamentals
as of 16/09/2026- Market cap
- $203.47B
- Shares out
- 540.63M
- P/E (trailing)
- 23.27
- P/E (forward)
- 15.46
- EPS (trailing)
- 16.17
- Dividend yield
- 2.64%
- Beta
- 0.43
- Profit margin
- 22.95%
- P/B
- 17.41
- Return on equity
- 74.80%
SEC financial statements
67 quarterly and 19 annual periods through 30/06/2026.
Details
- Ticker
- AMGN
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 16/09/2026.
Tracked by Congress
23 filers · 2 on watchlist · 36 buys · 28 sells · ?: 2 · D: 27 · R: 35
- 26/08/2026David J. TaylorSellAmgen Inc. - Common Stock$1,001–$15,000
- 26/08/2026David J. TaylorSellAmgen Inc. - Common Stock$1,001–$15,000
- 12/08/2026Sheldon WhitehouseSell+Amgen Inc. - Common Stock$1,001–$15,000
- 15/04/2025Thomas H TubervilleWSellAmgen Inc$15,001–$50,000
- 27/03/2026Alan ArmstrongSellAmgen Inc. - Common Stock$15,001–$50,000
- 05/06/2026David J. TaylorBuyAmgen Inc. - Common Stock$1,001–$15,000
- 17/04/2026Maria Elvira SalazarSellAmgen Inc. - Common Stock$15,001–$50,000
- 24/03/2026Maria Elvira SalazarBuyAmgen Inc. - Common Stock$15,001–$50,000